Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Fibreoptic Nasotracheal Intubation: Intubation of Difficult airway patients with inadequate mouth opening with fibreoptic bronchoscopy
Control Intervention1: Dexmedetomidine: There will
Sponsors
DY Patil Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1 All patient giving consent 2 Patient undergoing elective oro-maxillo-facial and oral malignancy surgeries 3 Patients >18 years or 4 Patients of either sex 5 ASA grade I and II
Exclusion criteria
Exclusion criteria: 1 Patients not consenting 2 Patient with coagulopathies or on anticoagulants 3 Nasal mass or Adenoids 4 Patients with severe renal, hepatic, respiratory or cardiac diseases, infection at the site of the block, pregnancy and neuromuscular disorders 5 Patients with any known allergy to dexmedetomidine 6 Patients with any contraindication to dexmedetomidine 7 Lack of cooperation or effective communication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare between three different doses of dexmedetomidine for sedation on intubation condition in awake nasotracheal fiberoptic intubation. The primary objective is to compare between three groups: Intubation score, patientsâ?? tolerance, 3-point assessment score immediately after nasotracheal intubation, hemodynamic parameters and incidence of oxygen desaturation if any. Timepoint: To compare pre infusion, 5 mins after infusion, 10 mins after infusion, pre intubation, during intubation and post intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objective is to observe side effects of drug, if anyTimepoint: 1.5 years | — |
Countries
India
Contacts
Public ContactSanya Arora
DY Patil Hospital
Outcome results
None listed